404
Tyrosine Protein Kinase Fyn Market Analysis | 2021-2026
Tyrosine Protein Kinase Fyn Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2021-2026
Tyrosine kinase is defined as an enzyme that can transfer a phosphate group from adenosine triphosphate (ATP) to tyrosine residues of specific proteins inside a cell. Tyrosine kinases play a crucial role in many biological processes such as cell adhesion, integrin-mediated signaling, regulation of cell growth and survival, immune response, and cell motility among others.
Increasing number of people suffering from cancer across geographies, increasing cancer cases, ongoing research to treat Alzheimer's disease using kinase inhibitors are the factors driving the growth of tyrosine protein kinase fyn market.
North America accounted for the largest share of tyrosine protein kinase fyn market in 2020.
The cancer pain segment accounted for the largest share of tyrosine protein kinase fyn market in 2020.
AB Science SA (France), Bristol-Myers Squibb Co (The U.S), ValiRx Plc (UK), AstraZeneca Plc (UK), Zen-Bio Inc (The U.S), Merck KGaA (Germany), Biocompare, Inc. (The U.S), BioLegend, Inc. (The U.S), Thermo Fisher Scientific (The U.S) and Takara Bio Inc. (Japan) are among the key players in the tyrosine protein kinase fyn market.
The market is studied from 2016-2026.